NO852717L - Interferonpreparat. - Google Patents

Interferonpreparat.

Info

Publication number
NO852717L
NO852717L NO852717A NO852717A NO852717L NO 852717 L NO852717 L NO 852717L NO 852717 A NO852717 A NO 852717A NO 852717 A NO852717 A NO 852717A NO 852717 L NO852717 L NO 852717L
Authority
NO
Norway
Prior art keywords
interferon
cells
epithelial cells
cell
human
Prior art date
Application number
NO852717A
Other languages
English (en)
Norwegian (no)
Inventor
Allan P Jarvis Jr
David I Kosowsky
Original Assignee
Damon Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Damon Biotech Inc filed Critical Damon Biotech Inc
Publication of NO852717L publication Critical patent/NO852717L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/80—Elimination or reduction of contamination by undersired ferments, e.g. aseptic cultivation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/804—Single cell protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO852717A 1984-07-06 1985-07-05 Interferonpreparat. NO852717L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/628,327 US4614651A (en) 1981-07-12 1984-07-06 Interferon epsilon

Publications (1)

Publication Number Publication Date
NO852717L true NO852717L (no) 1986-01-07

Family

ID=24518423

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852717A NO852717L (no) 1984-07-06 1985-07-05 Interferonpreparat.

Country Status (12)

Country Link
US (1) US4614651A (fr)
JP (1) JPS6124600A (fr)
AU (1) AU4193685A (fr)
BE (1) BE902688A (fr)
CA (1) CA1228037A (fr)
CH (1) CH666050A5 (fr)
DK (1) DK256385A (fr)
FR (1) FR2567132B1 (fr)
GB (1) GB2161487B (fr)
IT (1) IT1199893B (fr)
NO (1) NO852717L (fr)
SE (1) SE8501534L (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870163A (en) * 1985-08-29 1989-09-26 New York Blood Center, Inc. Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor
US5316775A (en) * 1988-08-04 1994-05-31 Kremers-Urban Company Method of treating hepatitis B infection
US5334395A (en) * 1988-08-04 1994-08-02 Kremers-Urban Company Method of treating an epstein-barr viral infection
US5284664A (en) * 1988-08-04 1994-02-08 Kremers-Urban Company Method of treating the symptoms of Alzheimer's disease
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
US5496926A (en) 1992-01-19 1996-03-05 Yeda Research And Development Co. Ltd. Process of preparing a soluble LDL receptor
IL102915A (en) * 1992-01-19 2005-12-18 Yeda Res & Dev Soluble ldl receptor and its preparation
WO2000032778A2 (fr) * 1998-12-01 2000-06-08 Genentech, Inc. Methodes et compositions permettant d'inhiber la croissance de cellules neoplasiques
ZA9811070B (en) 1997-12-08 2000-07-03 Genentech Inc Type I interferons.
EP1037995A1 (fr) 1997-12-08 2000-09-27 Genentech, Inc. Interferon-epsilon humain: interferon de type 1
JP2002526078A (ja) * 1998-09-18 2002-08-20 ザイモジェネティクス，インコーポレイティド インターフェロン−イプシロン
BRPI0507169A (pt) 2004-02-02 2007-06-26 Ambrx Inc polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
US8114630B2 (en) * 2007-05-02 2012-02-14 Ambrx, Inc. Modified interferon beta polypeptides and their uses
MX344166B (es) 2008-02-08 2016-12-07 Ambrx Inc Leptina-polipeptidos modificados y sus usos.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3699222A (en) * 1958-03-11 1972-10-17 Nat Res Dev Production of viral interfering substances
US3256152A (en) * 1965-06-14 1966-06-14 Merck & Co Inc Concentration and purification of interferons, viral inhibiting substances (vis), viral inhibiting factors (vif), or viral inhibitory material
DE1617401A1 (de) * 1966-05-02 1972-02-17 Centre Nat Rech Scient Verfahren zur Herstellung von Interferon-Praeparaten
DE1963998A1 (de) * 1968-12-24 1970-11-12 Takeda Chemical Industries Ltd Interferon induzierendes Mittel,Verfahren zu seiner Herstellung und Verfahren zur Interferon-Induktion durch Verwendung dieses Mittels
US4016036A (en) * 1975-11-14 1977-04-05 Massachusetts Institute Of Technology Process for serially culturing keratinocytes
EP0014050A3 (fr) * 1979-01-16 1980-10-01 Beecham Group Plc Production d'interféron
JPS56135420A (en) * 1980-03-26 1981-10-22 Fumiaki Taguchi Suppressive substance of virus and its preparation
JPS56167624A (en) * 1980-05-29 1981-12-23 Toray Ind Inc Method of interferon production
JPS57171924A (en) * 1981-04-15 1982-10-22 Fumiaki Taguchi Virus controlling substance and its preparation
DK319883A (da) * 1982-07-12 1984-01-13 Damon Biotech Inc Interferonpraeparat

Also Published As

Publication number Publication date
US4614651A (en) 1986-09-30
CA1228037A (fr) 1987-10-13
SE8501534D0 (sv) 1985-03-28
JPS6124600A (ja) 1986-02-03
IT8567622A0 (it) 1985-07-05
BE902688A (fr) 1985-10-16
IT1199893B (it) 1989-01-05
CH666050A5 (de) 1988-06-30
AU4193685A (en) 1986-01-09
DK256385D0 (da) 1985-06-06
FR2567132B1 (fr) 1988-12-30
GB2161487A (en) 1986-01-15
FR2567132A1 (fr) 1986-01-10
DK256385A (da) 1986-01-07
SE8501534L (sv) 1986-01-07
GB8517165D0 (en) 1985-08-14
GB2161487B (en) 1988-03-09

Similar Documents

Publication Publication Date Title
Oppermann et al. A joint product of the genes gag and pol of avian sarcoma virus: a possible precursor of reverse transcriptase
Derynck et al. Isolation and structure of a human fibroblast interferon gene
Merigan et al. Purification and characterization of vertebrate interferons
NO852717L (no) Interferonpreparat.
DE3587512T2 (de) Hüllenantigene vom menschlichen Immunodefizienz-Virus und deren Verwendungen.
DE68929467T3 (de) HIV-2 Varianten
US5540923A (en) Interferon proteins
Huang et al. Respiratory syncytial virus mRNA coding assignments
Deibel JR et al. Denaturation/refolding of purified recombinant HIV reverse transcriptase yields monomeric enzyme with high enzymatic activity
EP0287076B1 (fr) Récepteur du groupe récepteur mineur de rhinovirus
Shadduck et al. Fractionation of antibodies to L-cell colony-stimulating factor by affinity chromatography
NO832517L (no) Interferonpreparat, samt fremgangsmaate for dets fremstilling
Krempien et al. Purification of chick interferon by zinc chelate affinity chromatography and sodium dodecylsulfate-polyacrylamide gel electrophoresis
EP0048283B1 (fr) Substance inhibant les virus et procede de preparation de celle-ce
Fojo et al. The isolation and characterization of a colony stimulating factor from human lung
Carter et al. Porcine leukocyte interferon and antiviral activity in human cells
US4675282A (en) Assay for interferon epsilon
Billiau et al. Production of crude human interferon with high specific activity
Pestka Production and analysis of proteins by recombinant DNA technology
EP0458918B1 (fr) Procede d'obtention d'une proteine recombinante et son utilisation pour la detection du virus de la peste porcine africaine (vppa)
Kaufmann et al. Steroid‐1‐dehydrogenases in nocardioform bacteria studied by electrophoresis and immuno blotting techniques
Anfinsen Human interferon
RU2039823C1 (ru) Способ получения рекомбинантного лимфотоксина человека
Havell [72] Production and quantitation of neutralizing antibodies for human fibroblast interferon
Braude et al. Isolation of a biologically active fragment of human alpha interferon